Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/8/2026

Management of HCV‑Positive Patients with Coagulopathy and Septic Shock

Immediate Septic Shock Management (Surviving Sepsis Campaign)

  • Administer broad‑spectrum antibiotics within the first hour after sepsis recognition, after obtaining blood cultures – strong recommendation (Grade 1A) 1
  • Give an initial crystalloid bolus of 30 mL/kg for hypoperfusion and target a mean arterial pressure ≥65 mm Hg – strong recommendation (Grade 1A) 1
  • Start norepinephrine as the first‑line vasopressor if hypotension persists after adequate fluid resuscitation – strong recommendation (Grade 1A) 4
  • Identify and control the infection source as rapidly as possible – strong recommendation (Grade 1A) 1

Venous Thrombo‑Embolism (VTE) Prophylaxis in Severe Coagulopathy (Surviving Sepsis Campaign)

  • Pharmacologic thromboprophylaxis (unfractionated or low‑molecular‑weight heparin) is contraindicated when severe coagulopathy, thrombocytopenia, active bleeding, or recent intracerebral hemorrhage are present – strong recommendation (Grade 1A) 1, 2, 3, 5
  • Apply mechanical prophylaxis immediately—graduated compression stockings or intermittent pneumatic compression devices to the lower limbs – strong recommendation (Grade 1A) 1, 2, 3, 6
  • Continue mechanical prophylaxis unless peripheral vascular disease or active lower‑extremity infection precludes its use – moderate recommendation (Grade 2B) 1
  • Switch to pharmacologic prophylaxis once coagulation parameters improve and bleeding risk declines – moderate recommendation (Grade 2B) 1, 2, 3

Monitoring and Management of Sepsis‑Induced Coagulopathy (International Society on Thrombosis and Haemostasis)

  • Serially monitor platelet count, PT/INR, and fibrinogen to assess severity and trajectory of coagulopathy – strong recommendation (Grade 1A) 7
  • Diagnose sepsis‑induced coagulopathy (SIC) using platelet count, PT, and the SOFA score, which detects coagulopathy earlier than traditional DIC criteria – strong recommendation (Grade 1A) 7
  • Do not transfuse fresh‑frozen plasma solely to correct laboratory abnormalities when there is no active bleeding or planned invasive procedure – strong recommendation (Grade 1A) 8, 4, 9

Platelet Transfusion Thresholds (Intensive Care Medicine Guidelines)

  • Transfuse platelets prophylactically when the count falls below 10 × 10⁹/L in the absence of bleeding – moderate recommendation (Grade 2B) 8, 4, 9
  • Consider prophylactic platelet transfusion when the count is < 20 × 10⁹/L if the patient has a high bleeding risk – moderate recommendation (Grade 2B) 8, 4, 9
  • Maintain platelet counts ≥ 50 × 10⁹/L for patients with active bleeding, undergoing surgery, or requiring invasive procedures – strong recommendation (Grade 1A) 8, 4, 9

Stress‑Ulcer Prophylaxis (Surviving Sepsis Campaign)

  • Provide stress‑ulcer prophylaxis with a proton‑pump inhibitor or an H₂‑receptor antagonist in patients with septic shock and coagulopathy – strong recommendation (Grade 1A) 1, 2, 3, 5

Nutritional Support (Surviving Sepsis Campaign)

  • Start early enteral nutrition within 48 h of ICU admission if tolerated – strong recommendation (Grade 1A) 1, 2
  • Begin with low‑dose feeding (≈ 500 kcal/day) and advance as tolerated – moderate recommendation (Grade 2B) 1, 2
  • Avoid parenteral nutrition during the first week when enteral feeding is feasible – moderate recommendation (Grade 2B) 1, 2

Renal Replacement Therapy (Surviving Sepsis Campaign)

  • Use continuous renal replacement therapy (CRRT) for acute kidney injury in hemodynamically unstable patients to aid fluid balance – strong recommendation (Grade 1A) 1, 3, 5
  • Both continuous and intermittent modalities are acceptable overall, depending on patient stability and resource availability – moderate recommendation (Grade 2B) 1, 3

HCV‑Specific Considerations (Clinical and Molecular Hepatology Guidelines)

  • Defer decisions regarding antiviral therapy for hepatitis C until the patient is hemodynamically stable – expert opinion (Grade C) 10, 11
  • HCV infection does not contraindicate any standard sepsis management interventions – expert opinion (Grade C) 10, 11

Common Pitfalls to Avoid (Surviving Sepsis Campaign)

  • Never give heparin products when severe coagulopathy is documented, as this markedly increases hemorrhagic complications – strong recommendation (Grade 1A) 1, 6
  • Do not delay initiation of mechanical prophylaxis while awaiting improvement in coagulation parameters; VTE risk remains high – strong recommendation (Grade 1A) 1, 2
  • Avoid correcting coagulation abnormalities with fresh‑frozen plasma unless there is active bleeding or an urgent invasive procedure; no mortality benefit and risk of fluid overload – strong recommendation (Grade 1A) 8, 4, 9
  • Do not use antithrombin concentrate for treatment of septic shock; it is not recommended – strong recommendation (Grade 1A) 8, 4, 9

REFERENCES

6

other supportive therapies in sepsis. [LINK]

Intensive Care Medicine, 2001